The Weekly Litigation News Digest is now live. Subscribe now

Stabilized Transdermal Drug Delivery System - EP2299989

The patent EP2299989 was granted to Mylan on Jan 2, 2019. The application was originally filed on May 29, 2009 under application number EP09770655A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2299989

MYLAN
Application Number
EP09770655A
Filing Date
May 29, 2009
Status
Opposition Rejected
Apr 2, 2022
Publication Date
Jan 2, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AMWOct 2, 2019BECKORD & NIEDLICH PATENTANWALTE PARTG MBBADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO9518603
INTERNATIONAL-SEARCH-REPORTUS2006099242
INTERNATIONAL-SEARCH-REPORTUS2006188558
INTERNATIONAL-SEARCH-REPORTUS4832953
OPPOSITIONDE19629468
OPPOSITIONDE19906152
OPPOSITIONEP1671626
OPPOSITIONUS2006099242
OPPOSITIONUS2006188558
OPPOSITIONUS4832953
OPPOSITIONWO2004058247
OPPOSITIONWO2008115371
OPPOSITIONWO9518603
SEARCHDE19629468
SEARCHDE19906152
SEARCHEP1671626
SEARCHWO2008115371

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents